Flinton Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $13.6M | Buy |
267,960
+83,272
| +45% | +$4.22M | 0.42% | 47 |
|
|
2019
Q2 | $8.38M | Buy |
184,688
+138,936
| +304% | +$6.3M | 0.26% | 77 |
|
|
2019
Q1 | $2.18M | Buy |
45,752
+18,928
| +71% | +$903K | 0.07% | 203 |
|
|
2018
Q4 | $1.39M | Sell |
26,824
-3,752
| -12% | -$195K | 0.05% | 237 |
|
|
2018
Q3 | $1.9M | Sell |
30,576
-476
| -2% | -$29.5K | 0.06% | 224 |
|
|
2018
Q2 | $1.72M | Sell |
31,052
-5,964
| -16% | -$330K | 0.06% | 236 |
|
|
2018
Q1 | $2.34M | Buy |
37,016
+5,964
| +19% | +$377K | 0.08% | 192 |
|
|
2017
Q4 | $1.9M | Buy |
31,052
+14,476
| +87% | +$887K | 0.06% | 210 |
|
|
2017
Q3 | $1.06M | Buy |
+16,576
| New | +$1.06M | 0.04% | 265 |
|
|
2017
Q1 | – | Sell |
-17,808
| Closed | -$1.04M | – | 849 |
|
|
2016
Q4 | $1.04M | Buy |
+17,808
| New | +$1.04M | 0.05% | 237 |
|